Cargando…
A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
In some cases, drug combinations affect adverse outcome phenotypes by binding the same protein; however, drug‐binding proteins are associated through protein–protein interaction (PPI) networks within the cell, suggesting that drug phenotypes may result from long‐range network effects. We first used...
Autores principales: | Wilson, Jennifer L., Steinberg, Ethan, Racz, Rebecca, Altman, Russ B., Shah, Nigam, Grimes, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662203/ https://www.ncbi.nlm.nih.gov/pubmed/36204824 http://dx.doi.org/10.1002/psp4.12861 |
Ejemplares similares
-
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development
por: Wilson, Jennifer L., et al.
Publicado: (2018) -
The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis
por: Mao, Yimin, et al.
Publicado: (2017) -
PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein–protein interaction network
por: Wang, Xiaowen, et al.
Publicado: (2022) -
Synergistic Allostery in Multiligand-Protein Interactions
por: Ghode, Abhijeet, et al.
Publicado: (2020) -
A simple feature construction method for predicting upstream/downstream signal flow in human protein-protein interaction networks
por: Mei, Suyu, et al.
Publicado: (2015)